{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:44:01Z","timestamp":1762659841549},"publisher-location":"New York, NY","reference-count":44,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493997978"},{"type":"electronic","value":"9781493997985"}],"license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-4939-9798-5_11","type":"book-chapter","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T13:03:02Z","timestamp":1566392582000},"page":"213-224","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Microfluidic Manufacturing of Multitargeted PLGA\/PEG Nanoparticles for Delivery of Taxane Chemotherapeutics"],"prefix":"10.1007","author":[{"given":"Cl\u00e1udia","family":"Martins","sequence":"first","affiliation":[]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"8","key":"11_CR1","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1158\/1535-7163.Mct-09-0366","volume":"8","author":"EA Perez","year":"2009","unstructured":"Perez EA (2009) Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther 8(8):2086\u20132095. \n                  https:\/\/doi.org\/10.1158\/1535-7163.Mct-09-0366","journal-title":"Mol Cancer Ther"},{"issue":"Suppl 2","key":"11_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1634\/theoncologist.9-suppl_2-3","volume":"9","author":"J Gligorov","year":"2004","unstructured":"Gligorov J, Lotz JP (2004) Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 9(Suppl 2):3\u20138","journal-title":"Oncologist"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-3-319-67132-1_2","volume-title":"Micro and nanomanufacturing volume II","author":"A Elhissi","year":"2018","unstructured":"Elhissi A, Mahmood R, Parveen I, Vali A, Ahmed W, Jackson MJ (2018) Taxane formulations: from plant to clinic. In: Jackson MJ, Ahmed W (eds) Micro and nanomanufacturing volume II. Springer, Cham, pp 23\u201333. \n                  https:\/\/doi.org\/10.1007\/978-3-319-67132-1_2"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/DDDT.S28997","volume":"6","author":"JA Yared","year":"2012","unstructured":"Yared JA, Tkaczuk KHR (2012) Update on taxane development: new analogs and new formulations. Drug Des Devel Ther 6:371\u2013384. \n                  https:\/\/doi.org\/10.2147\/DDDT.S28997","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"11_CR5","first-page":"54","volume":"7","author":"MR Harrison","year":"2009","unstructured":"Harrison MR, Holen KD, Liu G (2009) Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins. Clin Adv Hematol Oncol 7(1):54\u201364","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"11_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2009.11.012","volume":"143","author":"G Gaucher","year":"2010","unstructured":"Gaucher G, Marchessault RH, Leroux J-C (2010) Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release 143(1):2\u201312. \n                  https:\/\/doi.org\/10.1016\/j.jconrel.2009.11.012","journal-title":"J Control Release"},{"issue":"2","key":"11_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2012.07.006","volume":"334","author":"L Feng","year":"2013","unstructured":"Feng L, Mumper RJ (2013) A critical review of lipid-based nanoparticles for taxane delivery. Cancer Lett 334(2):157\u2013175. \n                  https:\/\/doi.org\/10.1016\/j.canlet.2012.07.006","journal-title":"Cancer Lett"},{"issue":"1","key":"11_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijpharm.2011.01.028","volume":"407","author":"R Reul","year":"2011","unstructured":"Reul R, Renette T, Bege N, Kissel T (2011) Nanoparticles for paclitaxel delivery: a comparative study of different types of dendritic polyesters and their degradation behavior. Int J Pharm 407(1):190\u2013196. \n                  https:\/\/doi.org\/10.1016\/j.ijpharm.2011.01.028","journal-title":"Int J Pharm"},{"issue":"2","key":"11_CR9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1021\/nl104117p","volume":"11","author":"EM Enlow","year":"2011","unstructured":"Enlow EM, Luft JC, Napier ME, DeSimone JM (2011) Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings. Nano Lett 11(2):808\u2013813. \n                  https:\/\/doi.org\/10.1021\/nl104117p","journal-title":"Nano Lett"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3389\/fphar.2018.01260","volume":"9","author":"S Rezvantalab","year":"2018","unstructured":"Rezvantalab S, Drude NI, Moraveji MK, G\u00fcvener N, Koons EK, Shi Y, Lammers T, Kiessling F (2018) PLGA-based nanoparticles in cancer treatment. Front Pharmacol 9:1260\u20131260. \n                  https:\/\/doi.org\/10.3389\/fphar.2018.01260","journal-title":"Front Pharmacol"},{"issue":"1","key":"11_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/2211738505666161230110108","volume":"5","author":"P Rafiei","year":"2017","unstructured":"Rafiei P, Haddadi A (2017) Pharmacokinetic consequences of PLGA nanoparticles in docetaxel drug delivery. Pharm Nanotechnol 5(1):3\u201323. \n                  https:\/\/doi.org\/10.2174\/2211738505666161230110108","journal-title":"Pharm Nanotechnol"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.colsurfb.2012.06.024","volume":"101","author":"NM Khalil","year":"2013","unstructured":"Khalil NM, TCFd N, Casa DM, Dalmolin LF, ACd M, Hoss I, Romano MA, Mainardes RM (2013) Pharmacokinetics of curcumin-loaded PLGA and PLGA\u2013PEG blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces 101:353\u2013360. \n                  https:\/\/doi.org\/10.1016\/j.colsurfb.2012.06.024","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"6","key":"11_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.tips.2016.03.003","volume":"37","author":"J Kroon","year":"2016","unstructured":"Kroon J, Kooijman S, Cho N-J, Storm G, van der Pluijm G (2016) Improving taxane-based chemotherapy in castration-resistant prostate cancer. Trends Pharmacol Sci 37(6):451\u2013462. \n                  https:\/\/doi.org\/10.1016\/j.tips.2016.03.003","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"11_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jcis.2010.10.024","volume":"354","author":"Z Song","year":"2011","unstructured":"Song Z, Feng R, Sun M, Guo C, Gao Y, Li L, Zhai G (2011) Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J Colloid Interface Sci 354(1):116\u2013123. \n                  https:\/\/doi.org\/10.1016\/j.jcis.2010.10.024","journal-title":"J Colloid Interface Sci"},{"issue":"9","key":"11_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/1061186x.2016.1198354","volume":"24","author":"S Garg","year":"2016","unstructured":"Garg S, Heuck G, Ip S, Ramsay E (2016) Microfluidics: a transformational tool for nanomedicine development and production. J Drug Target 24(9):821\u2013835. \n                  https:\/\/doi.org\/10.1080\/1061186x.2016.1198354","journal-title":"J Drug Target"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejpb.2018.01.014","volume":"138","author":"Cl\u00e1udia Martins","year":"2019","unstructured":"Martins C, Ara\u00fajo F, Gomes MJ, Fernandes C, Nunes R, Li W, Santos HA, Borges F, Sarmento B (2018) Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy. Eur J Pharm Biopharm. \n                  https:\/\/doi.org\/10.1016\/j.ejpb.2018.01.014","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"5","key":"11_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/17425247.2018.1446936","volume":"15","author":"JP Martins","year":"2018","unstructured":"Martins JP, Torrieri G, Santos HA (2018) The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems. Expert Opin Drug Deliv 15(5):469\u2013479. \n                  https:\/\/doi.org\/10.1080\/17425247.2018.1446936","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"11_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12951-018-0339-0","volume":"16","author":"A Gdowski","year":"2018","unstructured":"Gdowski A, Johnson K, Shah S, Gryczynski I, Vishwanatha J, Ranjan A (2018) Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials. J Nanobiotechnol 16(1):12\u201312. \n                  https:\/\/doi.org\/10.1186\/s12951-018-0339-0","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"11_CR19","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1039\/c2cs15327k","volume":"41","author":"M Elsabahy","year":"2012","unstructured":"Elsabahy M, Wooley KL (2012) Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 41(7):2545\u20132561. \n                  https:\/\/doi.org\/10.1039\/c2cs15327k","journal-title":"Chem Soc Rev"},{"key":"11_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201701035","volume":"7","author":"C Martins","year":"2017","unstructured":"Martins C, Sousa F, Ara\u00fajo F, Sarmento B (2017) Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications. Adv Healthc Mater 7:1701035. \n                  https:\/\/doi.org\/10.1002\/adhm.201701035","journal-title":"Adv Healthc Mater"},{"issue":"7","key":"11_CR21","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1039\/c2cs15294k","volume":"41","author":"R Mout","year":"2012","unstructured":"Mout R, Moyano DF, Rana S, Rotello VM (2012) Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev 41(7):2539\u20132544. \n                  https:\/\/doi.org\/10.1039\/c2cs15294k","journal-title":"Chem Soc Rev"},{"issue":"16","key":"11_CR22","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1039\/C3CS60036J","volume":"42","author":"L Feng","year":"2013","unstructured":"Feng L, Zhu C, Yuan H, Liu L, Lv F, Wang S (2013) Conjugated polymer nanoparticles: preparation, properties, functionalization and biological applications. Chem Soc Rev 42(16):6620\u20136633. \n                  https:\/\/doi.org\/10.1039\/C3CS60036J","journal-title":"Chem Soc Rev"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/B978-0-323-46144-3.00010-6","volume-title":"Nanostructures for cancer therapy","author":"BP Bastakoti","year":"2017","unstructured":"Bastakoti BP, Liu Z (2017) Multifunctional polymeric micelles as therapeutic nanostructures: targeting, imaging, and triggered release. In: Ficai A, Grumezescu AM (eds) Nanostructures for cancer therapy. Elsevier, Amsterdam, pp 261\u2013283. \n                  https:\/\/doi.org\/10.1016\/B978-0-323-46144-3.00010-6"},{"issue":"10","key":"11_CR24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1021\/ar200054n","volume":"44","author":"J Shi","year":"2011","unstructured":"Shi J, Xiao Z, Kamaly N, Farokhzad OC (2011) Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc Chem Res 44(10):1123\u20131134. \n                  https:\/\/doi.org\/10.1021\/ar200054n","journal-title":"Acc Chem Res"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jconrel.2014.02.002","volume":"180","author":"D Pfister","year":"2014","unstructured":"Pfister D, Morbidelli M (2014) Process for protein PEGylation. J Control Release 180:134\u2013149. \n                  https:\/\/doi.org\/10.1016\/j.jconrel.2014.02.002","journal-title":"J Control Release"},{"issue":"7","key":"11_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.7150\/thno.14856","volume":"6","author":"Y Chen","year":"2016","unstructured":"Chen Y, Xianyu Y, Wu J, Yin B, Jiang X (2016) Click chemistry-mediated nanosensors for biochemical assays. Theranostics 6(7):969\u2013985. \n                  https:\/\/doi.org\/10.7150\/thno.14856","journal-title":"Theranostics"},{"issue":"26","key":"11_CR27","doi-asserted-by":"publisher","first-page":"8982","DOI":"10.1039\/C7NR01020F","volume":"9","author":"X Q-s","year":"2017","unstructured":"Q-s X, H-m D, Ma Y-q (2017) Can dual-ligand targeting enhance cellular uptake of nanoparticles? Nanoscale 9(26):8982\u20138989. \n                  https:\/\/doi.org\/10.1039\/C7NR01020F","journal-title":"Nanoscale"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nantod.2017.12.007","volume":"18","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Feijen J, Zhong Z (2018) Dual-targeted nanomedicines for enhanced tumor treatment. Nano Today 18:65\u201385. \n                  https:\/\/doi.org\/10.1016\/j.nantod.2017.12.007","journal-title":"Nano Today"},{"issue":"1","key":"11_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11481-016-9687-4","volume":"12","author":"H Gao","year":"2017","unstructured":"Gao H (2017) Perspectives on dual targeting delivery systems for brain tumors. J Neuroimmune Pharmacol 12(1):6\u201316. \n                  https:\/\/doi.org\/10.1007\/s11481-016-9687-4","journal-title":"J Neuroimmune Pharmacol"},{"issue":"44","key":"11_CR30","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1002\/smll.201501056","volume":"11","author":"L Xiong","year":"2015","unstructured":"Xiong L, Du X, Kleitz F, Qiao SZ (2015) Cancer-cell-specific nuclear-targeted drug delivery by dual-ligand-modified mesoporous silica nanoparticles. Small 11(44):5919\u20135926. \n                  https:\/\/doi.org\/10.1002\/smll.201501056","journal-title":"Small"},{"issue":"15","key":"11_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201800106","volume":"7","author":"Y Liu","year":"2018","unstructured":"Liu Y, Hui Y, Ran R, Yang G-Z, Wibowo D, Wang H-F, Middelberg APJ, Zhao C-X (2018) Synergetic combinations of dual-targeting ligands for enhanced in vitro and in vivo tumor targeting. Adv Healthc Mater 7(15):1800106. \n                  https:\/\/doi.org\/10.1002\/adhm.201800106","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"11_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.nano.2012.05.015","volume":"9","author":"DR Elias","year":"2013","unstructured":"Elias DR, Poloukhtine A, Popik V, Tsourkas A (2013) Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomedicine 9(2):194\u2013201. \n                  https:\/\/doi.org\/10.1016\/j.nano.2012.05.015","journal-title":"Nanomedicine"},{"issue":"3","key":"11_CR33","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1039\/c2cs35265f","volume":"42","author":"J Nicolas","year":"2013","unstructured":"Nicolas J, Mura S, Brambilla D, Mackiewicz N, Couvreur P (2013) Design, functionalization strategies and biomedical applications of targeted biodegradable\/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev 42(3):1147\u20131235. \n                  https:\/\/doi.org\/10.1039\/c2cs35265f","journal-title":"Chem Soc Rev"},{"issue":"2","key":"11_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0014-5793(91)80700-D","volume":"284","author":"YL Khmelnitsky","year":"1991","unstructured":"Khmelnitsky YL, Belova AB, Levashov AV, Mozhaev VV (1991) Relationship between surface hydrophilicity of a protein and its stability against denaturation by organic solvents. FEBS Lett 284(2):267\u2013269","journal-title":"FEBS Lett"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-4939-7312-5_20","volume-title":"Recombinant glycoprotein production","author":"F Sousa","year":"2018","unstructured":"Sousa F, Fonte P, Cruz A, Kennedy PJ, Pinto IM, Sarmento B (2018) Polyester-based nanoparticles for the encapsulation of monoclonal antibodies. In: Pican\u00e7o-Castro V, Swiech K (eds) Recombinant glycoprotein production, vol 1674. Springer, New York, NY, pp 239\u2013253. \n                  https:\/\/doi.org\/10.1007\/978-1-4939-7312-5_20"},{"issue":"40","key":"11_CR36","doi-asserted-by":"publisher","first-page":"12486","DOI":"10.1073\/pnas.1517048112","volume":"112","author":"AJ Clark","year":"2015","unstructured":"Clark AJ, Davis ME (2015) Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core. Proc Natl Acad Sci U S A 112(40):12486\u201312491. \n                  https:\/\/doi.org\/10.1073\/pnas.1517048112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"11_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jconrel.2005.03.026","volume":"106","author":"A Matsumoto","year":"2005","unstructured":"Matsumoto A, Matsukawa Y, Suzuki T, Yoshino H (2005) Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide). J Control Release 106(1):172\u2013180. \n                  https:\/\/doi.org\/10.1016\/j.jconrel.2005.03.026","journal-title":"J Control Release"},{"issue":"1","key":"11_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157341309787314566","volume":"5","author":"U Dragan","year":"2009","unstructured":"Dragan U, Magdalena S (2009) Poly(lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Curr Nanosci 5(1):1\u201314. \n                  https:\/\/doi.org\/10.2174\/157341309787314566","journal-title":"Curr Nanosci"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejpb.2018.03.005","volume":"127","author":"PJ Kennedy","year":"2018","unstructured":"Kennedy PJ, Perreira I, Ferreira D, Nestor M, Oliveira C, Granja PL, Sarmento B (2018) Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles. Eur J Pharm Biopharm 127:366\u2013370. \n                  https:\/\/doi.org\/10.1016\/j.ejpb.2018.03.005","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"11_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/pharmaceutics10040267","volume":"10","author":"Enrica Chiesa","year":"2018","unstructured":"Chiesa E, Dorati R, Pisani S, Conti B, Bergamini G, Modena T, Genta I (2018) The microfluidic technique and the manufacturing of polysaccharide nanoparticles. Pharmaceutics 10(4). \n                  https:\/\/doi.org\/10.3390\/pharmaceutics10040267","journal-title":"Pharmaceutics"},{"issue":"10","key":"11_CR41","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s10483-016-2131-9","volume":"37","author":"J Lin","year":"2016","unstructured":"Lin J, Pan X, Yin Z, Ku X (2016) Solution of general dynamic equation for nanoparticles in turbulent flow considering fluctuating coagulation. Appl Math Mech 37(10):1275\u20131288. \n                  https:\/\/doi.org\/10.1007\/s10483-016-2131-9","journal-title":"Appl Math Mech"},{"issue":"11","key":"11_CR42","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1039\/c7lc00242d","volume":"17","author":"D Liu","year":"2017","unstructured":"Liu D, Zhang H, Fontana F, Hirvonen J, Santos HA (2017) Microfluidic-assisted fabrication of carriers for controlled drug delivery. Lab Chip 17(11):1856\u20131883. \n                  https:\/\/doi.org\/10.1039\/c7lc00242d","journal-title":"Lab Chip"},{"issue":"5555","key":"11_CR43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1126\/science.1066238","volume":"295","author":"AD Stroock","year":"2002","unstructured":"Stroock AD, Dertinger SK, Ajdari A, Mezic I, Stone HA, Whitesides GM (2002) Chaotic mixer for microchannels. Science 295(5555):647\u2013651. \n                  https:\/\/doi.org\/10.1126\/science.1066238","journal-title":"Science"},{"issue":"5","key":"11_CR44","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00348-003-0753-3","volume":"36","author":"KV Sharp","year":"2004","unstructured":"Sharp KV, Adrian RJ (2004) Transition from laminar to turbulent flow in liquid filled microtubes. Exp Fluids 36(5):741\u2013747. \n                  https:\/\/doi.org\/10.1007\/s00348-003-0753-3","journal-title":"Exp Fluids"}],"container-title":["Methods in Molecular Biology","Drug Delivery Systems"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9798-5_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T13:05:52Z","timestamp":1566392752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9798-5_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"ISBN":["9781493997978","9781493997985"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9798-5_11","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"22 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}